Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Mayne Pharma (MYX AU)
Watchlist
225
Analysis
Health Care
•
Australia
Mayne Pharma Group Ltd. develops and manufactures oral pharmaceuticals. The Company produces branded generics, specialty generics, and active pharmaceutical ingredients.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Mayne Pharma
•
13 May 2025 10:37
Mayne Pharma (MYX AU): MAC Musings
Quantifying the pharma EO impact is not straightforward. My read is that the market has taken an unjustified negative view. Trading wide at a 6.9%...
David Blennerhassett
Follow
834 Views
Share
bullish
•
ESR
•
12 May 2025 01:26
Merger Arb Mondays (12 May) - ESR, NTT Data, Shibaura, Torii, Imagica, Zeekr, Sinarmas, Gold Road
We summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan,...
Arun George
Follow
864 Views
Share
bullish
•
NTT Data Corp
•
11 May 2025 06:30
Last Week in Event SPACE: NTT Data Corp, Zeekr, Shibaura Electronics, Swire Pacific/ThaiNamthip
It’s Sunday! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed during the...
David Blennerhassett
Follow
597 Views
Share
bullish
•
Torii Pharmaceutical
•
11 May 2025 06:15
(Mostly) Asia-Pac M&A: Torii Pharma, Mitsu. Shokuhin, Domain, Gold Road, Canvest, Shibaura, Tsuruha
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
Follow
453 Views
Share
bullish
•
Domain Holdings Australia
•
09 May 2025 14:43
Domain Holdings (DHG AU): CoStar’s A$4.43 Binding Proposal a Done Deal
Nine's support suggests that this is a done deal. At the last close and for an end-of-August payment, the gross/annualised spread is 1.1%/3.6%.
Arun George
Follow
550 Views
Share
First
Previous
26
27
28
29
30
31
32
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x